AMS’ CryoGen Purchase Anticipates Expanded HerOption Applications
This article was originally published in The Gray Sheet
Executive Summary
American Medical Systems will seek to extend HerOption endometrial ablation technology for fibroid treatment following the firm's acquisition of CryoGen